Lung cancer rates lower at higher elevations
the ONA take:
According to a new study published in the journal Peerj, researchers from the University of Pennsylvania Perelman School of Medicine in Philadelphia, Pennsylvania, and the University of California Department of Biological and Medical Informatics in San Francisco, California, have found that lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
For the study, the researchers sought to investigate whether inhaled oxygen could be a carcinogen by analyzing cancer incidence rates across the Western United States.
They found that as the county elevation increased, lung cancer rates decreased. Specifically, lung cancer incidence decreased by 7.23 cases per 100,000 individuals for every 1,000-meter elevation increasing. The researchers accounted for various variables, such as smoking prevalence and education.
The authors note, however, that the observed association does not prove a causal effect between oxygen and lung cancer. They also evaluated rates of breast, colorectal, and prostate cancer, and found a weak association or no association between elevation and incidence.
The findings will probably not persuade individuals to relocate, but the identification of a universal and major risk factor for lung cancer may lead to better treatments and preventative approaches.
Lung cancer rates are lower at higher elevations, suggesting that atmospheric oxygen may have a role in lung carcinogenesis.
- Neurotoxicity After CAR T-cell Therapy May Be Associated With Endothelial Activation
- Navigation Programs Most Effective in Increasing Follow-up Colonoscopy
- Specialized Interventions Reduce Aberrant Opioid Behaviors in Cancer Patients
- New Class of Clinical Trial Enhances Research on Cancer Care Delivery
- Nivolumab Provides Better Long-Term Efficacy Compared With Docetaxel in NSCLC
- Anticancer Properties of The Probiotic Kefir: A Review
- Navigating the Transition From Treatment to Breast Cancer Survivor
- Combining Radiation, Immunotherapy: An Emerging Challenge for Oncology Nursing
- Naldemedine Effective for Opioid-Induced Constipation in Cancer Pain
- Disruptions to Circadian Rhythm Linked to Prostate Cancer Surgery Regret
- Case Report of a KIT-mutated Melanoma Patient With an Excellent Response to Apatinib and Temozolomide Combination Therapy
- Novel Predictive Model More Effectively Identifies Risk for Lung Cancer
- Long-Term Eltrombopag Increases Platelet Counts, Decreases Bleeding in ITP
- Overall Survival Increase for Melanoma Brain Metastases
- Prophylactic Prochloperazine Ineffective for Opioid-induced Nausea/Vomiting in Cancer
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|